-+ 0.00%
-+ 0.00%
-+ 0.00%

LB Pharmaceuticals Q2 EPS $(1.71) Misses $(0.80) Estimate

Benzinga·08/11/2026 12:05:20
Listen to the news
LB Pharmaceuticals (NASDAQ:LBRX) reported quarterly losses of $(1.71) per share which missed the analyst consensus estimate of $(0.80) by 113.75 percent. This is a 87.41 percent increase over losses of $(13.58) per share from the same period last year.